Medicare Enrolled
Dr. Brian Mitchell, M.D.
Neurology · Athens, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mitchell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mitchell?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mitchell
Dr. Brian Mitchell is a neurology specialist in Athens, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mitchell performed 34,481 Medicare services across 1,370 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mitchell received a total of $4,158 from 51 pharmaceutical and/or device companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mitchell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in GA
$4,158 industry payments
Medicare Practice Summary
Medicare Utilization ↗34,481
Medicare services
Top 2% in GA for neurology
1,370
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,724 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
32,825 | $4 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
490 | $80 | $318 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
235 | $115 | $431 |
| New patient office visit, complex (60-74 min) | 141 | $139 | $530 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
98 | $64 | $300 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
80 | $131 | $600 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 77 | $50 | $200 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
76 | $112 | $901 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
74 | $138 | $2,000 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
48 | $123 | $706 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $61 | $227 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
45 | $123 | $475 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
43 | $38 | $200 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
32 | $118 | $1,600 |
| MRI of upper spine without contrast An MRI scan of the upper spinal canal that does not use contrast dye. This imaging test uses magnetic fields and radio waves to create detailed pictures of the spine. |
25 | $130 | $2,000 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
23 | $94 | $1,200 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
21 | $86 | $220 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
16 | $215 | $2,800 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
16 | $156 | $2,000 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $90 | $438 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
15 | $8 | $60 |
| MRI of head blood vessels without contrast An MRI scan that creates detailed images of the blood vessels in the head without using contrast dye. |
13 | $149 | $2,000 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
13 | $37 | $500 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
11 | $271 | $1,250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,158
Total received (2018-2024)
Avg $594/year across 7 years
Top 40% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
291
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,138 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,224
2023
$1,200
2022
$617
2021
$532
2020
$98
2019
$276
2018
$211
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$208
SK Life Science, Inc.
$100
PFIZER INC.
$89
Eisai Inc.
$88
Novartis Pharmaceuticals Corporation
$81
Amgen Inc.
$73
UCB, Inc.
$70
Lundbeck LLC
$61
TG Therapeutics, Inc.
$52
Octapharma USA, Inc.
$40
Alexion Pharmaceuticals, Inc.
$40
Biogen, Inc.
$39
ACADIA Pharmaceuticals Inc
$37
Lilly USA, LLC
$36
Takeda Pharmaceuticals U.S.A., Inc.
$30
Teva Pharmaceuticals USA, Inc.
$28
Xeris Pharmaceuticals, Inc.
$25
ARGENX US, INC.
$21
Ipsen Biopharmaceuticals, Inc
$21
SCILEX PHARMACEUTICALS INC.
$19
Vanda Pharmaceuticals Inc.
$18
Amneal Pharmaceuticals LLC
$17
ANI Pharmaceuticals, Inc.
$16
Resmed Corp
$14
Top 3 companies account for 32.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$749
Teva Pharmaceuticals USA, Inc.
$225
Novartis Pharmaceuticals Corporation
$211
Lundbeck LLC
$208
UCB, Inc.
$191
Sunovion Pharmaceuticals Inc.
$167
PFIZER INC.
$161
Biogen, Inc.
$158
SK Life Science, Inc.
$142
AbbVie Inc.
$138
Amgen Inc.
$132
Alexion Pharmaceuticals, Inc.
$130
Allergan Inc.
$119
Lilly USA, LLC
$101
ACADIA Pharmaceuticals Inc
$96
Horizon Therapeutics plc
$90
Eisai Inc.
$88
ARGENX US, INC.
$67
Supernus Pharmaceuticals, Inc.
$64
EMD Serono, Inc.
$63
Allergan, Inc.
$56
TG Therapeutics, Inc.
$52
Amneal Pharmaceuticals LLC
$48
Catalyst Pharmaceuticals, Inc.
$43
Biohaven Pharmaceuticals, Inc.
$40
Octapharma USA, Inc.
$40
Xeris Pharmaceuticals, Inc.
$39
Ipsen Biopharmaceuticals, Inc
$37
ANI Pharmaceuticals, Inc.
$36
Janssen Pharmaceuticals, Inc
$35
Mallinckrodt Hospital Products Inc.
$33
Alnylam Pharmaceuticals Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$30
Otsuka America Pharmaceutical, Inc.
$25
Scilex Pharmaceuticals Inc.
$24
Marinus Pharmaceuticals, Inc.
$24
Amylyx Pharmaceuticals, Inc.
$22
TG THERAPEUTICS, INC.
$21
E.R. Squibb & Sons, L.L.C.
$19
Greenwich Biosciences, Inc.
$19
JAZZ PHARMACEUTICALS INC.
$19
SCILEX PHARMACEUTICALS INC.
$19
HARMONY BIOSCIENCES LLC
$19
Vanda Pharmaceuticals Inc.
$18
Upsher-Smith Laboratories LLC
$17
UPSHER-SMITH LABORATORIES LLC
$16
Biohaven Pharmaceutical Holding Company Ltd.
$15
BANNER LIFE SCIENCES, LLC
$15
IMPEL PHARMACEUTICALS INC.
$14
Resmed Corp
$14
GENZYME CORPORATION
$14
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AIRSENSE · AJOVY · AMVUTTRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · DAYBUE · DUOPA · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · GILENYA · HYQVIA · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · Leqembi · MAVENCLAD · NAMZARIC · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · ONPATTRO · OXTELLAR XR · PANZYGA · PAXLOVID · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RELYVRIO · REXULTI · RYTARY · Rebif · SOLIRIS · Soliris · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Wakix · ZEPOSIA · ZTALMY · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
21
Per 100K population
16.2
County median income
$52,267
Nearest hospital
ST MARY'S HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mitchell is a mixed practice specialist, with above-average Medicare volume (top 2% in GA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mitchell experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Mitchell performed 32,825 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mitchell receive payments from pharmaceutical companies?
Yes. Dr. Mitchell received a total of $4,158 from 51 companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mitchell's costs compare to other neurologists in Athens?
Dr. Mitchell's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mitchell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Athens
Browse neurologists in Athens ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology